BMY vs GEVO · P/E 17, rev $24.46B vs rev $89.4M
Bristol-Myers Squibb Company (BMY) versus Gevo Inc (GEVO) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Gevo Inc (GEVO) is a specialty chemicals company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported GEVO revenue for 2026-06-30 was $89.4M. Net income was -$198.6M. GEVO currently screens at market cap $378.5M.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. GEVO currently screens at market cap $378.5M.
Not investment advice. Open the BMY and GEVO stock pages for the full models.
Not investment advice.